This review describes in detail the phytochemistry and neurological effects of the medicinal herb Centella
asiatica (L.) Urban. C. asiatica is a small perennial plant that grows in moist, tropical and
sub-tropical regions throughout the world. Phytochemicals identified from C. asiatica to date include isoprenoids
(sesquiterpenes, plant sterols, pentacyclic triterpenoids and saponins) and phenylpropanoid derivatives (eugenol derivatives,
caffeoylquinic acids, and flavonoids). Contemporary methods for fingerprinting and characterization of compounds in C.
asiatica extracts include liquid chromatography and/or ion mobility spectrometry in conjunction with high-resolution
mass spectrometry. Multiple studies in rodent models, and a limited number of human studies support C.
asiatica’s traditional reputation as a cognitive enhancer, as well as its anxiolytic and anticonvulsant effects.
Neuroprotective effects of C.asiatica are seen in several in vitro models, for example against
beta amyloid toxicity, and appear to be associated with increased mitochondrial activity, improved antioxidant status, and/or
inhibition of the pro-inflammatory enzyme, phospholipase A2. Neurotropic effects of C. asiatica include increased
dendritic arborization and synaptogenesis, and may be due to modulations of signal transduction pathways such as ERK1/2 and Akt.
Many of these neurotropic and neuroprotective properties of C.asiatica have been associated with the triterpene
compounds asiatic acid, asiaticoside and madecassoside. More recently, caffeoylquinic acids are emerging as a second important
group of active compounds in C. asiatica, with the potential of enhancing the Nrf2-antioxidant response pathway.
The absorption, distribution, metabolism and excretion of the triterpenes, caffeoylquinic acids and flavonoids found in C.
asiatica have been studied in humans and animal models, and the compounds or their metabolites found in the brain.
This review highlights the remarkable potential for C. asiatica extracts and derivatives to be used in the
treatment of neurological conditions, and considers the further research needed to actualize this possibility.
Scope: We previously showed that two hydrogenated xanthohumol (XN) derivatives, α,βdihydro-XN (DXN) and tetrahydro-XN (TXN), improved parameters of metabolic syndrome (MetS), a critical risk factor of cardiovascular disease (CVD) and type 2 diabetes, in a dietinduced obese murine model. We hypothesized that improvements in obesity and MetS are linked to changes in the composition of the gut microbiota, bile acid metabolism, intestinal barrier function and inflammation. Methods and results: To test this hypothesis, we sequenced 16S rRNA genes and measured bile acids in fecal samples from C57BL/6J mice fed a high-fat diet (HFD) or HFD containing XN, DXN or TXN. We measured the expression of genes associated with epithelial barrier function, inflammation, and bile acid metabolism, in the colon, white adipose tissue (WAT), and liver, respectively. Administration of XN derivatives decreased intestinal microbiota diversity and abundance, specifically Bacteroidetes and Tenericutes, altered bile acid metabolism, and reduced inflammation. In WAT, TXN supplementation decreased pro-inflammatory gene expression by suppressing macrophage infiltration. Transkingdom network analysis connected changes in the microbiota to improvements in MetS in the host. Conclusion: Changes in the gut microbiota and bile acid metabolism may explain, in part, the improvements in obesity and MetS associated with administration of XN and its derivatives.
The female flowers of the hop plant have long been used as a preservative and a flavoring agent in beer, but they are now being included in some herbal preparations for women for "breast enhancement." This study investigated the relative estrogenic, androgenic and progestogenic activities of the known phytoestrogen, 8-prenylnaringenin, and structurally related hop flavonoids. 6-Prenylnaringenin, 6,8-diprenylnaringenin and 8-geranylnaringenin exhibited some estrogenicity, but their potency was less than 1% of that of 8-prenylnaringenin. 8-Prenylnaringenin alone competed strongly with 17ss-estradiol for binding to both the alpha- and ss-estrogen receptors. None of the compounds (xanthohumol, isoxanthohumol, 8-prenyl-naringenin, 6-prenylnaringenin, 3'-geranylchalconaringenin, 6-geranylnaringenin, 8-geranylnaringenin, 4'-O:-methyl-3'-prenylchalconaringenin and 6,8-diprenylnaringenin) nor polyphenolic hop extracts showed progestogenic or androgenic bioactivity. These results indicate that the endocrine properties of hops and hop products are due to the very high estrogenic activity of 8-prenylnaringenin and concern must be expressed about the unrestricted use of hops in herbal preparations for women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.